Zura Bio
Kim A Davis is currently serving as the EVP, General Counsel, and Corporate Secretary at Zura Bio Limited. Prior to this, Kim held various legal and compliance roles at companies such as Arena Pharmaceuticals, kaléo Inc., Impax Laboratories, and Amgen Inc. Kim obtained her Doctor of Law (J.D.) degree cum laude from Pepperdine Law, and her Bachelor of Arts (B.A.) degree cum laude from Sweet Briar College.
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.